Basic Information
ACIS is a leading company in human vascular tissue engineering. VACIS has developed in-situ tissue-engineered blood vessels, offering a novel therapeutic option for vascular surgeries. The failure of artificial vascular grafts is a common complication in vascular surgery, associated with high morbidity and medical costs. VACIS provides patients with autologous grafts that maintain long-term patency.